BioSpace News Archive

Business

Owlstone Medical Appoints Dr Andy Richards CBE to Board of Directors

Owlstone Medical Ltd. announced today the addition of Dr Andy Richards CBE to its Board as a Non-Executive Director.

September 17, 2018
·
5 min read
Business

Realm Therapeutics Slashes Staff and Explores Potential Sale as the Company Conducts a Strategic Review

Following a trial failure with its atopic dermatitis treatment, Malvern, Penn.-based Realm Therapeutics has opted to discontinue all of its drug development programs and is considering a potential sale of the company.

September 17, 2018
·
2 min read
·
Alex Keown
Policy

Genentech and Hemophilia Patients Eye Oct. 4 for Hemlibra Ruling

Hemophilia patients could have an easier time taking their medication if the U.S. Food and Drug Administration (FDA) gives the green light for the newest indication of Genentech’s Hemlibra for patients who do not have Factor VIII inhibitors.

September 17, 2018
·
3 min read
·
Alex Keown
Policy

House Rejects Senate Bill Provision to Require Disclosure of Drug Prices in Television Commercials

The U.S. House of Representatives has split with the Senate over requiring pharmaceutical companies to disclose the list price of their prescription medications in television advertisements.

September 17, 2018
·
2 min read
·
Alex Keown
Business

Medtronic Joins Catalyst CEO Champions For Change and Pledges to Accelerate Women Into Management and Board Seats

Medtronic CEO Omar Ishrak Commits to Continue Accelerating Diversity, Inclusion and Gender Equality

September 17, 2018
·
2 min read
Oxurion NV to present further scientific findings supporting therapeutic potential of THR-317 and THR-687 as promising new therapies for Diabetic Eye Disease at upcoming EURETINA 2018 in Vienna, Austria

Oxurion NV announced today that it will give two presentations at the Euretina International Congress, which is being held in Vienna, Austria, from 20 to 23 September 2018.

September 17, 2018
·
4 min read
Drug Development

GamaMabs Pharma starts a phase 2 study of monoclonal antibody GM102 in patients with advanced or metastatic colorectal cancer

C201 phase 2 will study immuno-enhancer antibody GM102, targeting AMHRII as a single agent and in combination with Trifluridine/Tipiracil (Lonsurf®)

September 17, 2018
·
3 min read
Business

BIA Separations Expands with New Upstream Processing Facility

Investment in new lab will support integrated optimisation of upstream and downstream process development

September 17, 2018
·
2 min read
Shuwen Biotech‘s PD-L1 Detection Kit Validated in Clinical Trials of Leading Drugs

Patients with advanced esophageal squamous cell carcinoma with higher PD-L1 expression can benefit better from leading PD-1 antibody drugs

September 17, 2018
·
2 min read
Microdispensing of adhesives

Perfect dispensing results in the μl area using the endless piston principle

September 17, 2018
·
6 min read